Therapy of obstetrical infections with moxalactam.
We evaluated moxalactam in 62 patients with puerperal or postabortal genital infections. In all patients, the initial dose was 6 g/day. In 84% of patients, we found anaerobes in genital specimens. Of aerobic isolates, only enterococci were resistant. Among anaerobes tested, only two isolates (a Clos...
Zapisane w:
| Wydane w: | Antimicrob Agents Chemother |
|---|---|
| Główni autorzy: | , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
American Society for Microbiology (ASM)
1980
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283919/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6447473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.6.1004 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|